Smith & Wesson Beats Q2 Earnings Estimates, Cuts Outlook

Smith & Wesson Holding Corp. (SWHC – Snapshot Report) reported second-quarter fiscal 2015 (ending Oct 31, 2014) earnings from continuing operations of 9 cents per share, beating the Zacks Consensus Estimate by 2 cents. The number was, however, lower than the year-ago earnings of 28 cents per share as sales remained weak. Smith & Wesson Holding Corporation –…

Europe (In 2 Ridiculous Charts)

Consider: European stocks just closed at their highest since Jan 2008; Spanish bond yields hit a record low 1.803% and Spanish youth unemployment hovers near a record high 53.8%; Italian bond yields hit a record low 1.72% and Italian youth unemployment is at a record 43.3%. So once again we ask, why exactly does Europe need…

E

Amgen (AMGN) reported on December 3, 2014 that the FDA has approved their Leukemia drug Blincyto (blinatumomab) for the treatment of Philadelphia Chromosome-negative  Relapsed or Refractory B-cell precursor Acute Lymphoblastic Leukemia. This disease is an uncommon form of blood cancer where patients had few or no treatment options. With the approval of Blincyto patients now…

US Daily Cash Deficit 12/4/2014

The U.S. Daily Cash Deficit for Thursday 12/4/2014 was $6.2B bringing the December 2014 Deficit through 4 days to $66B. As is typical, I have taken the liberty of adjusting by days of the week in an attempt to sync up 2014 and 2013 to give us a little bit more accurate picture of the…

Global Deflationary Pressures Are Mounting

Consumers often gripe that government price data understate the true nature of inflation. Nonetheless, it’s safe to say that the cost of goods and services has been rising at a steadily slower rate in most countries. In fact, according to GaveKal Capital, global inflation just hit a 59-month low. And the recent, steep decline in the price of…